Affiliation:
1. Department of Medical Microbiology and Immunology, School of Medicine, University of California, Davis, Davis, California
Abstract
ABSTRACT
Treatment with streptomycin enhances the growth of human commensal
Escherichia coli
isolates in the mouse intestine, suggesting that the resident microbial community (microbiota) can inhibit the growth of invading microbes, a phenomenon known as “colonization resistance.” However, the precise mechanisms by which streptomycin treatment lowers colonization resistance remain obscure. Here we show that streptomycin treatment rendered mice more susceptible to the development of chemically induced colitis, raising the possibility that the antibiotic might lower colonization resistance by changing mucosal immune responses rather than by preventing microbe-microbe interactions. Investigation of the underlying mechanism revealed a mild inflammatory infiltrate in the cecal mucosa of streptomycin-treated mice, which was accompanied by elevated expression of
Nos2
, the gene that encodes inducible nitric oxide synthase. In turn, this inflammatory response enhanced the luminal growth of
E. coli
by nitrate respiration in a
Nos2
-dependent fashion. These data identify low-level intestinal inflammation as one of the factors responsible for the loss of resistance to
E. coli
colonization after streptomycin treatment.
IMPORTANCE
Our intestine is host to a complex microbial community that confers benefits by educating the immune system and providing niche protection. Perturbation of intestinal communities by streptomycin treatment lowers “colonization resistance” through unknown mechanisms. Here we show that streptomycin increases the inflammatory tone of the intestinal mucosa, thereby making the bowel more susceptible to dextran sulfate sodium treatment and boosting the
Nos2-
dependent growth of commensal
Escherichia coli
by nitrate respiration. These data point to the generation of alternative electron acceptors as a by-product of the inflammatory host response as an important factor responsible for lowering resistance to colonization by facultative anaerobic bacteria such as
E. coli
.
Publisher
American Society for Microbiology
Reference64 articles.
1. Studies on the habitation of pathogenic Escherichia coli in the intestinal tract of mice. I. Comparative experiments on the habitation of each type of resistant pathogenic Escherichia coli under an administration of streptomycin;Saito K;Paediatr. Jpn.,1961
2. Studies on the habitation of pathogenic Escherichia coli in the intestinal tract of mice. II. Experimental inoculation of type 055 Escherichia coli after long-term administration of streptomycin;Saito K;Paediatr. Jpn.,1961
3. Altered colonizing ability for mouse large intestine of a surface mutant of a human faecal isolate of Escherichia coli;Myhal ML;J. Gen. Microbiol.,1983
4. An
Escherichia coli
MG1655 Lipopolysaccharide Deep-Rough Core Mutant Grows and Survives in Mouse Cecal Mucus but Fails To Colonize the Mouse Large Intestine
5. Colonization of the streptomycin-treated mouse large intestine by a human fecal Escherichia coli strain: role of adhesion to mucosal receptors
Cited by
176 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献